UK scraps embryo fee hike

Plans to increase embryo research license fees 30-fold have been abandoned

Written byLinda Nordling
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The British government's fertility watchdog has scrapped plans for a 30-fold increase in embryo research license fees, The Scientist has learned. The news was greeted with great relief by researchers.

The Human Fertilisation and Embryology Authority (HFEA) earlier this year published plans to increase its fees for processing research licenses from £200 (USD $360) to £6000 (USD $10,700) in order to comply with government regulations. The plans met with criticism from the research community, and UK stem cell scientists in particular warned that it would stifle research in their discipline.

Then, the HFEA saw little hope in finding money from elsewhere as UK government guidelines state that the cost of regulation should be met by those being regulated.

But a senior HFEA official, speaking on condition of anonymity, said this week that the controversial plans have been shelved. The Department of Health has decided that it will allow the HFEA ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies